Treatment strategies in gastric cancer;Behandlungsstrategien beim magenkarzinom

Deutsches Arzteblatt

Volumn 108, Issue 41, 2011, Pages 698-706

  Meyer, Hans Joachim ^a   Wilke, Hansjochen ^b  

^a STÄDTISCHES KLINIKUM SOLINGEN   (Germany)

^b KLINIKEN ESSEN MITTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DATA BASE; ENDOSCOPIC SURGERY; ESOPHAGEAL ADENOCARCINOMA; GASTROINTESTINAL CARCINOMA; GASTROJEJUNOSTOMY; HISTOLOGY; HUMAN; INFORMATION PROCESSING; LYMPHADENECTOMY; METASTASIS; MINIMALLY INVASIVE PROCEDURE; MULTIMODALITY CANCER THERAPY; PERIOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL (TOPIC); STOMACH ADENOCARCINOMA; STOMACH MUCOSA; TOTAL STOMACH RESECTION; TUMOR BIOPSY;

CHEMORADIOTHERAPY; ENDOSCOPY, GASTROINTESTINAL; GASTRECTOMY; HUMANS; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 82155164396     PISSN: 00121207     EISSN: 01722107     Source Type: Journal    
DOI: 10.3238/arztebl.2011.0698     Document Type: Article

References (25)

1. Keoghley MRB: Gastrointestinal cancers in Europe. Aliment Pharmacol Ther 2003; 18: 7-30.
2. Grundmann RT, Hölscher AH, Bembenek A, Bollschweiler E, Drognitz O, Feuerbach S, et al.: Diagnostik und Therapie des Magenkarzinoms - Workflow. Zentralbl Chir 2009; 134: 362-74.
3. Hartgrink HH, Jansen EPM, von Grieken NCT, van de Velde CJH: Gastric Cancer. Lancet 2009; 374: 477-90.
4. Moehler M, Al-Batran SE, Andus T, Anthuber M, Arends J, Arnold D, et al.: S3-Leitlinie "Magenkarzinom" - Diagnostik und Therapie der Adenokarzinome des Magens und oesophagogastralen Übergangs. Z Gastroenterol 2011; 49: 461-531.
5. Englisch-Fritz C, Hünerbein M, Porschen R: Diagnostik beim Magenkarzinom. Onkologe 2008; 14: 332-8.
6. Kwee RM, Kwee TC: Imaging in local staging of gastric cancer: A systematic review. J Clin Oncol 2007; 25: 2107-16. (Pubitemid 46972798)
7. Schuhmacher C, Sendler A, Meyer H-J: Chirurgische Therapie des Magenkarzinoms. Onkologe 2008; 14: 339-49.
8. Rabenstein T, Ell C, Feussner H: Endoskopische Resektion und minimal- invasive Verfahren beim Magenkarzinom. Onkologe 2008; 14: 350-61.
9. Meyer H-J: The influence of case load and the extent of resection on the quality of treatment outcome in gastric cancer. EJSO 2005; 31: 595-604.
10. Gotoda T, Yanagisawa A, Sasako M, Ono H, Nakanishi Y, Shimoda T, et al.: Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer 2000; 3: 219-25. (Pubitemid 32290729)
11. Gemmill EH, McCulloch P: Systematic review of minimally invasive resection for gastro-oesophageal cancer. Br J Surg 2007; 94: 1461-7. (Pubitemid 350275623)
12. Bozzetti F, Marubini E, Bonfanti G, Miceli R, Piano C, Crose N, et al.: Total versus subtotal gastrectomy: surgical morbidity and mortality rates in a multicenter Italian randomized trial. The Italian Gastointestinal Tumor Study Group. Ann Surg 1997; 226: 613-20. (Pubitemid 28049657)
13. Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJ, Welvaart K, Songun I, et al.: Extended lymph-node dissection for gastric cancer. N Engl J Med 1999; 340: 908-14. (Pubitemid 29141051)
14. Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, et al.: Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 1999; 79: 1522-30. (Pubitemid 29116815)
15. Siewert JR, Böttcher K, Stein HJ, Roder JD and the German Gastric Carcinoma Study Group: Relevant prognostic factors in gastric cancer. Ten-Year results of the German Gastric Cancer Study: Ann Surg 1998; 228: 449-61. (Pubitemid 30194389)
16. McCulloch P, Niita ME, Kazi H, Gama-Rodrigues JJ: Gastrectomy with extended lymphadenectomy for primary treatment of gastric cancer. Br J Surg 2005; 92: 5-13. (Pubitemid 40144187)
17. Songun I, Putter H, Meershoek-Klein Kranenbarg E, Sasako M, van de Velde CJH: Surgical treatment of gastric cancer: 15-year followup results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 2010; 11: 439-49.
18. Sasako M, Sano T, Yamamoto S, Kurokawa Y, Nashimoto A, Kurita A, et al.: D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 2008; 359: 453-62.
19. The GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) Group: Benefit of adjuvant chemotherapy for resectable gastric cancer. JAMA 2010; 303: 1729-37.
20. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al.: Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001; 345: 725-30.
21. Cunningham D, Allum WH, Stenning SP, Thompson JN, van de Velde CJ, Nicolson M, et al.: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006; 355: 11-20.
22. Ychou M, Boige V, Pignon JP, Conroy T, Bouché O, Lebreton G, et al.: Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: An FNCLCC and FFCD multicenter phase III trial. J Clin Oncol 2011; 29: 1715-21.
23. Stahl M, Walz MK, Stuschke M, Lehmann N, Meyer HJ, Riera-Knorrenschild J, et al.: Phase III comparison of preoperative chemotherapy compared with chemoradio-therapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol 2009; 27: 851-6.
24. Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, Van Cutsem E: Gastric cancer. Crit Rev Oncol Hematol 2009; 71: 127-64.
25. Van Cutsem E, Kang YK, Chung HC, Shen L, Sawaki A, Lordick F, et al.: Efficacy results from the ToGA trial: a phase III study of trastuzumab added to standard chemotherapy in first-line human epidermal growth factor receptor 2 (HER2)-positive advanced gastric cancer. J Clin Oncol 2009; 27: 798s (abstract LBA4509).